Systemic treatment of adult atopic dermatitis: a review
M Megna, M Napolitano, C Patruno, A Villani… - Dermatology and …, 2017 - Springer
Atopic dermatitis (AD) is a common chronic inflammatory skin disease that predominantly
affects children. However, it can persist in adulthood and/or start at older ages. Due to its …
affects children. However, it can persist in adulthood and/or start at older ages. Due to its …
Quorum sensing between bacterial species on the skin protects against epidermal injury in atopic dermatitis
Colonization of the skin by Staphylococcus aureus is associated with exacerbation of atopic
dermatitis (AD), but any direct mechanism through which dysbiosis of the skin microbiome …
dermatitis (AD), but any direct mechanism through which dysbiosis of the skin microbiome …
Efficacy and safety of abrocitinib and upadacitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
Q Gao, Y Zhao, J Zhang - Heliyon, 2023 - cell.com
Background: The sparsity of head-to-head trials for medications used as in atopic dermatitis
(AD) treatment makes therapy options difficult. Objective: To better compare the efficacy and …
(AD) treatment makes therapy options difficult. Objective: To better compare the efficacy and …
Sézary syndrome and atopic dermatitis: comparison of immunological aspects and targets
I Saulite, W Hoetzenecker, S Weidinger… - BioMed research …, 2016 - Wiley Online Library
Sézary syndrome (SS), an aggressive form of erythrodermic pruritic cutaneous T cell
lymphoma (CTCL), from an immunological perspective characterized by increased Th2 …
lymphoma (CTCL), from an immunological perspective characterized by increased Th2 …
Investigational drugs for atopic dermatitis
KL Hon, AKC Leung, TNH Leung… - Expert Opinion on …, 2018 - Taylor & Francis
Introduction: Many novel medications and herbal medicines have claimed efficacy on atopic
dermatitis (AD). Areas covered: This review covers evidence on efficacy of topical and oral …
dermatitis (AD). Areas covered: This review covers evidence on efficacy of topical and oral …
Experimental drugs with the potential to treat atopic eczema
KLE Hon, VPY Chan, AKC Leung - Journal of experimental …, 2021 - Taylor & Francis
Introduction Eczema or atopic dermatitis (AD) is a chronically relapsing dermatosis
characterized by pruritus and a significant impact on the quality of life. Methods The authors …
characterized by pruritus and a significant impact on the quality of life. Methods The authors …
The Effect of Osthole on Transient Receptor Potential Channels: A Possible Alternative Therapy for Atopic Dermatitis
NK Kordulewska, A Król-Grzymała - Journal of Inflammation …, 2024 - Taylor & Francis
Introduction Chronic recurrent skin inflammation and severe itching in patients with atopic
dermatitis (AD) significantly impair their quality of life. The H4 histamine receptor plays a key …
dermatitis (AD) significantly impair their quality of life. The H4 histamine receptor plays a key …
Inhibitory Effect of Mistletoe Ointment on DNCB-Induced Atopic Dermatitis in BALB/c Mice
CE Hong, SY Lyu - Scientia Pharmaceutica, 2023 - mdpi.com
Atopic dermatitis (AD) is increasingly prevalent globally. However, the frequent and
prolonged use of corticosteroids, which are commonly employed for AD treatment, carries …
prolonged use of corticosteroids, which are commonly employed for AD treatment, carries …
Topical E6005/RVT-501, a novel phosphodiesterase 4 inhibitor, for the treatment of atopic dermatitis
Introduction: Local adverse effects of steroid use and the burning sensation of calcineurin
inhibitors impair patients' adherence to treatment and decrease the treatment response in …
inhibitors impair patients' adherence to treatment and decrease the treatment response in …
An overview of drug discovery efforts for eczema: why is this itch so difficult to scratch?
KL Hon, S Loo, AKC Leung, JTS Li… - Expert Opinion on Drug …, 2020 - Taylor & Francis
Introduction: Atopic dermatitis (AD) is a type of allergic/inflammatory dermatitis characterized
by itch and an impairment in quality of life. Areas covered: Herein, the authors review drug …
by itch and an impairment in quality of life. Areas covered: Herein, the authors review drug …